Biotech Acquisition, Payments Network Shift, Large Insider Sell-off

1. Vertex Pharmaceuticals is set to acquire Crinetics Pharmaceuticals in a $10 billion deal, causing Crinetics shares to more than double.
2. Major banks like JPMorgan and Bank of America are exploring a deal to create a new payments network, potentially disrupting the industry and bypassing debit-card fee caps.
3. Rocket Lab officer Peter Beck plans to sell 5 million shares worth approximately $465 million, a move that could pressure the company's stock price.